SEARCH

SEARCH BY CITATION

References

  • Abbott JR, Palmer GH, Kegerreis KA, Hetrick PF, Howard CJ, Hope JC & Brown WC (2005) Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale. J Immunol 174: 67026715.
  • Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, McKenna DF, Nowakowski J, Munoz J & Dumler JS (1996) Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med 125: 904908.
  • Akkoyunlu M & Fikrig E (2000) Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect Immun 68: 18271833.
  • Asanovich KM, Bakken JS, Madigan JE, Aguero-Rosenfeld M, Wormser GP & Dumler JS (1997) Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J Infect Dis 176: 10291034.
  • Bakken JS & Dumler JS (2000) Human granulocytic ehrlichiosis. Clin Infect Dis 31: 554560.
  • Barbet AF, Yi J, Lundgren A, McEwen BR, Blouin EF & Kocan KM (2001) Antigenic variation of Anaplasma marginale: major surface protein 2 diversity during cyclic transmission between ticks and cattle. Infect Immun 69: 30573066.
  • Borjesson DL & Barthold SW (2002) The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions. Comp Med 52: 403413.
  • Brayton KA, Palmer GH, Lundgren A, Yi J & Barbet AF (2002) Antigenic variation of Anaplasma marginale msp2 occurs by combinatorial gene conversion. Mol Microbiol 43: 11511159.
  • Brown WC, Zhu D, Shkap V, McGuire TC, Blouin EF, Kocan KM & Palmer GH (1998) The repertoire of Anaplasma marginale antigens recognized by CD4(+) T-lymphocyte clones from protectively immunized cattle is diverse and includes major surface protein 2 (MSP-2) and MSP-3. Infect Immun 66: 54145422.
  • Brown WC, McGuire TC, Zhu D, Lewin HA, Sosnow J & Palmer GH (2001) Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses. J Immunol 166: 11141124.
  • Brown WC, Brayton KA, Styer CM & Palmer GH (2003) The hypervariable region of Anaplasma marginale major surface protein 2 (MSP2) contains multiple immunodominant CD4+ T lymphocyte epitopes that elicit variant-specific proliferative and IFN-gamma responses in MSP2 vaccinates. J Immunol 170: 37903798.
  • Brown WC, Palmer GH, Brayton KA, Meeus PF, Barbet AF, Kegerreis KA & McGuire TC (2004) CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3. Infect Immun 72: 36883692.
  • Buitrago MI, Ijdo JW, Rinaudo P, Simon H, Copel J, Gadbaw J, Heimer R, Fikrig E & Bia FJ (1998) Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin Infect Dis 27: 213215.
  • Bunnell JE, Trigiani ER, Srinivas SR & Dumler JS (1999) Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J Infect Dis 180: 546550.
  • Caspersen K, Park JH, Patil S & Dumler JS (2002) Genetic variability and stability of Anaplasma phagocytophila msp2 (p44). Infect Immun 70: 12301234.
  • Choi KS, Scorpio DG & Dumler JS (2004) Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B nuclear translocation. J Infect Dis 189: 19211925.
  • Dumler JS, Asanovich KM, Bakken JS, Richter P, Kimsey R & Madigan JE (1995) Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia. J Clin Microbiol 33: 10981103.
  • Dumler JS, Choi KS, Garcia-Garcia JC, Barat NS, Scorpio DG, Garyu JW, Grab DJ & Bakken JS (2005) Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis 11: 18281834.
  • Dunning Hotopp JC, Lin M, Madupu R et al. (2006) Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet 2: e21.
  • French DM, Brown WC & Palmer GH (1999) Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia. Infect Immun 67: 58345840.
  • Greig B, Asanovich KM, Armstrong PJ & Dumler JS (1996) Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs. J Clin Microbiol 34: 4448.
  • Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucleic Acids Symp Ser 41: 9598.
  • IJdo JW, Zhang Y, Hodzic E, Magnarelli LA, Wilson ML, Telford SR III, Barthold SW & Fikrig E (1997) The early humoral response in human granulocytic ehrlichiosis. J Infect Dis 176: 687692.
  • IJdo JW, Sun W, Zhang Y, Magnarelli LA & Fikrig E (1998) Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect Immun 66: 32643269.
  • IJdo JW, Wu C, Telford SR III & Fikrig E (2002) Differential expression of the p44 gene family in the agent of human granulocytic ehrlichiosis. Infect Immun 70: 52955298.
  • Lepidi H, Bunnell JE, Martin ME, Madigan JE, Stuen S & Dumler JS (2000) Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg 62: 2937.
  • Lin Q & Rikihisa Y (2005) Establishment of cloned Anaplasma phagocytophilum and analysis of p44 gene conversion within an Iinfected horse and infected SCID mice. Infect Immun 73: 51065114.
  • Lotric-Furlan S, Petrovec M, Avsic-Zupanc T & Strle F (2004) Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis. Scand J Infect Dis 36: 817822.
  • Madigan JE (1993) Equine ehrlichiosis. Vet Clin North Am Equine Pract 9: 423428.
  • Martin ME, Bunnell JE & Dumler JS (2000) Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J Infect Dis 181: 374378.
  • Martin ME, Caspersen K & Dumler JS (2001) Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol 158: 18811888.
  • Murphy CI, Storey JR, Recchia J, Doros-Richert LA, Gingrich-Baker C, Munroe K, Bakken JS, Coughlin RT & Beltz GA (1998) Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family. Infect Immun 66: 37113718.
  • Page RD (1996) TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 12: 357358.
  • Palmer GH, Eid G, Barbet AF, McGuire TC & McElwain TF (1994) The immunoprotective Anaplasma marginale major surface protein 2 is encoded by a polymorphic multigene family. Infect Immun 62: 38083816.
  • Park J, Choi KS & Dumler JS (2003) Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect Immun 71: 40184025.
  • Pusterla N, Madigan JE, Asanovich KM, Chae JS, Derock E, Leutenegger CM, Pusterla JB, Lutz H & Dumler JS (2000) Experimental inoculation with human granulocytic Ehrlichia agent derived from high- and low-passage cell culture in horses. J Clin Microbiol 38: 12761278.
  • Scorpio DG, Caspersen K, Ogata H, Park J & Dumler JS (2004) Restricted changes in major surface protein-2 (msp2) transcription after prolonged in vitro passage of Anaplasma phagocytophilum. BMC Microbiol 4: 1.
  • Scorpio DG, Von Loewenich FD, Gobel H, Bogdan C & Dumler JS (2006) Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury. Clin Vaccine Immunol 13: 806809.
  • Sun W, IJdo JW, Telford SR III, Hodzic E, Zhang Y, Barthold SW & Fikrig E (1997) Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest 100: 30143018.
  • Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F & Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 48764882.
  • Von Loewenich FD, Scorpio DG, Reischl U, Dumler JS & Bogdan C (2004) Frontline: control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. Eur J Immunol 34: 17891797.
  • Wang X, Rikihisa Y, Lai TH, Kumagai Y, Zhi N & Reed SM (2004) Rapid sequential changeover of expressed p44 genes during the acute phase of Anaplasma phagocytophilum infection in horses. Infect Immun 72: 68526859.
  • Wemme H, Pfeifer S, Heck R & Muller-Quernheim J (1992) Measurement of lymphocyte proliferation: critical analysis of radioactive and photometric methods. Immunobiology 185: 7889.
  • Zhi N, Rikihisa Y, Kim HY, Wormser GP & Horowitz HW (1997) Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J Clin Microbiol 35: 26062611.
  • Zhi N, Ohashi N, Rikihisa Y, Horowitz HW, Wormser GP & Hechemy K (1998) Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol 36: 16661673.
  • Zhi N, Ohashi N & Rikihisa Y (1999) Multiple p44 genes encoding major outer membrane proteins are expressed in the human granulocytic ehrlichiosis agent. J Biol Chem 274: 1782817836.
  • Zhi N, Ohashi N, Tajima T, Mott J, Stich RW, Grover D, Telford SR III, Lin Q & Rikihisa Y (2002) Transcript heterogeneity of the p44 multigene family in a human granulocytic ehrlichiosis agent transmitted by ticks. Infect Immun 70: 11751184.